EPLR 1/2018 (Vol. 2)

Editorial

Sabrina Röttger-Wirtz

Seite 1 - 2

A Transparency Challenge: Can Commercial Confidentiality In Clinical Trials Data Be Overcome?

Giulia Schneider

Seite 3 - 18

Austria ∙ Two Years Of Online Sales Of Medicinal Products In Austria

Sara Khalil, Andreas Natterer

Seite 19 - 25

Germany ∙ Compliance: 18 Months Of The German Act On Fighting Corruption In The Healthcare Sector

Christian Tillmanns

Seite 26 - 31

Italy Reforms Clinical Trial Rules

Marco de Morpurgo

Seite 32 - 36

The Netherlands Introduces A Statutory Ban On Inducement Related To Medical Devices

Hein van den Bos, Ruth Franken

Seite 37 - 41

Sweden ∙ Pharmaceutical Advertising In Sweden: Two New Guiding Decisions By The Industry’s Self-Regulatory Bodies

Helén Waxberg, Jenny Romin, Emmie Montgomery

Seite 42 - 46

The CJEU’s First Ruling On The Classification Of Software As A Medical Device: A Predictable Scenario With A Possible Cliff-hanger?

Eveline Van Keymeulen, Jacqueline Bore

Seite 47 - 55

Jurisdiction

Seite 56 - 57

New EU Pharmaceutical Law and Policy

Seite 58

7th Annual Pharma Law Convention: The Special Data & GDPR Edition

Jakob McKernan

Seite III - IV